Brief: Galenica - Sales Up 7.3% To CHF 1409.7 MLN In First Four Months 2026
BRIEF-Galenica - Sales Up 7.3% To CHF 1409.7 MLN In First Four Months 2026 May 28 (Reuters) - GALENICA AG GALE.S:
POSTS STRONG SALES GROWTH IN A CHALLENGING MARKET ENVIRONMENT
REPORTS SALES UP 7.3% TO CHF 1409.7 MILLION IN FIRST FOUR MONTHS 2026
HOME CARE BUSINESS UP 9.1% TO CHF 41.9 MILLION; DIAGNOSTICS CONTRIBUTED CHF 40.8 MILLION
CONFIRMS 2026 GUIDANCE FOR SALES GROWTH OF 5%-7% AND EBIT GROWTH OF 6%-8%
Further company coverage: GALE.S
(Gdansk Newsroom)
((Reuters Messaging: Gdansk.newsroom@thomsonreuters.com ; +48 58 7696600))
Recent news on Galenica AG
See all newsBrief: Galenica Successfully Places A Bond Of Over CHF 200 Million
Swiss stocks - Factors to watch on October 22
Brief: Galenica Sales Up 5.7% To CHF 3.17 Bln In First Nine Months Of 2026, Confirms Outlook
Swiss stocks - Factors to watch on September 2
Switzerland's Galenica H1 sales rise on pharmacy services demand